BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20007581)

  • 1. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
    Han B; Wu J
    J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
    Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
    J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
    J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
    Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
    Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
    Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
    Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B; Zhang ZL; Yu LY; Guo LH
    Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
    Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
    J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets.
    Cheng G; Zhu L; Mahato RI
    Mol Pharm; 2008; 5(6):1093-102. PubMed ID: 18828606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
    Sung HY; Wu HG; Ahn JH; Park WY
    Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation.
    Wu Y; Han B; Luo H; Roduit R; Salcedo TW; Moore PA; Zhang J; Wu J
    Diabetes; 2003 Sep; 52(9):2279-86. PubMed ID: 12941767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W; Zhang C; Chen C; Zhuang G
    Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes.
    Mellado-Gil JM; Aguilar-Diosdado M
    J Endocrinol; 2004 Oct; 183(1):155-62. PubMed ID: 15525583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signalling in islets.
    Persaud SJ; Muller D; Jones PM
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):290-3. PubMed ID: 18481944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.